Rivastigmine-loaded PLGA and PBCA nanoparticles: preparation, optimization, characterization, in vitro and pharmacodynamic studies.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  European journal of pharmaceutics and biopharmaceutics

• Publication date

  2010-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ejpb.2010.07.007PMID 20637869
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Quantifying drug release from PLGA nanoparticulates.

  2009cited by this paper
• Development, optimization and in vitro evaluation of alginate mucoadhesive microspheres of carvedilol for nasal delivery

  2009cited by this paper
• Cationic Polybutyl Cyanoacrylate Nanoparticles for DNA Delivery

  2009cited by this paper
• Intranasal Mucoadhesive Microemulsion of Tacrine to Improve Brain Targeting

  2008cited by this paper
• Buccal Bioadhesive Delivery System of 5-Fluorouracil: Optimization and Characterization

  2008cited by this paper
• Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease.

  2008cited by this paper
• Buccal bioadhesive delivery system of 5-fluorouracil: optimization and characterization.

  2008cited by this paper
• Core-shell type of nanoparticles composed of poly[(n-butyl cyanoacrylate)-co-(2-octyl cyanoacrylate)] copolymers for drug delivery application: synthesis, characterization and in vitro degradation.

  2006cited by this paper
• Optimization of pH-independent release of nicardipine hydrochloride extended-release matrix tablets using response surface methodology.

  2005cited by this paper
• Rivastigmine is a potent inhibitor of acetyl- and butyrylcholinesterase in Alzheimer's plaques and tangles.

  2005cited by this paper
• A new sunscreen of the cinnamate class: synthesis and enzymatic hydrolysis evaluation of glyceryl esters of p-methoxycinnamic acid.

  2005cited by this paper
• Formulation and evaluation of sustained release microspheres of poly-lactide-co-glycolide containing tamoxifen citrate

  2005cited by this paper
• Tissue distribution of methotrexate following administration as a solution and as a magnetic microsphere conjugate in rats bearing brain tumors

  2005cited by this paper
• Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles.

  2005cited by this paper
• Development of three layered buccal compact containing metoprolol tartrate by statistical optimization technique.

  2005cited by this paper
• PLGA nanoparticles in drug delivery: the state of the art.

  2004cited by this paper
• Influence of polymerization technique and experimental variables on the particle properties and release kinetics of methotrexate from poly(butylcyanoacrylate) nanoparticles.

  2004cited by this paper
• Pegylated poly(lactide) and poly(lactide-co-glycolide) nanoparticles: preparation, properties and possible applications in drug delivery.

  2004cited by this paper
• Polymer degradation and in vitro release of a model protein from poly(D,L-lactide-co-glycolide) nano- and microparticles.

  2003cited by this paper
• Preparation and drug release behaviors of nimodipine-loaded poly(caprolactone)-poly(ethylene oxide)-polylactide amphiphilic copolymer nanoparticles.

  2003cited by this paper
• Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis.

  2003cited by this paper
• Development of Controlled-Release Buccoadhesive Hydrophilic Matrices of Diltiazem Hydrochloride: Optimization of Bioadhesion, Dissolution, and Diffusion Parameters

  2002cited by this paper
• Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells.

  2002cited by this paper
• Response surface optimization of the critical medium components for the production of alkaline protease by a newly isolated Bacillus sp.

  2002cited by this paper
• Preparation, characterization, and drug release behaviors of drug nimodipine-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) amphiphilic triblock copolymer micelles.

  2002cited by this paper
• In Vitro and In Vivo Evaluation of Oral Heparin–Loaded Polymeric Nanoparticles in Rabbits

  2002cited by this paper
• Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity.

  2002cited by this paper
• Preparation of Poly(butyl cyanoacrylate) Nanoparticles by Aqueous Dispersion Polymerisation in the Presence of Insulin

  2001cited by this paper
• Poly n-butyl cyanoacrylate nanoparticles: a mechanistic study of polymerisation and particle formation.

  2001cited by this paper
• Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers.

  2001cited by this paper
• Preparation factors affecting the properties of polylactide nanoparticles: a factorial design study.

  2001cited by this paper
• Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA-mPEG nanoparticles.

  2001cited by this paper
• Nanoparticulate systems for brain delivery of drugs.

  2001cited by this paper
• Influence of particle size and dissolution conditions on the degradation properties of polylactide-co-glycolide particles.

  2000cited by this paper
• DOXORUBICIN-LOADED POLY(BUTYLCYANOACRYLATE) NANOPARTICLES PRODUCED BY EMULSIFIER-FREE EMULSION POLYMERIZATION

  2000cited by this paper
• Increase of the duration of the anticonvulsive activity of a novel NMDA receptor antagonist using poly(butylcyanoacrylate) nanoparticles as a parenteral controlled release system.

  2000cited by this paper
• Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method.

  1999cited by this paper
• Ketoprofen-poly(D,L-lactic-co-glycolic acid) microspheres: influence of manufacturing parameters and type of polymer on the release characteristics.

  1999cited by this paper
• The Burden of Dementia: A Medical and Research Perspective

  1999cited by this paper
• PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug.

  1999cited by this paper
• Significant Transport of Doxorubicin into the Brain with Polysorbate 80-Coated Nanoparticles

  1999cited by this paper
• Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study.

  1998cited by this paper
• Nanoparticle technology for delivery of drugs across the blood-brain barrier.

  1998cited by this paper
• Biodegradation and biocompatibility of PLA and PLGA microspheres.

  1997cited by this paper
• Delivery of Loperamide Across the Blood-Brain Barrier with Polysorbate 80-Coated Polybutylcyanoacrylate Nanoparticles

  1997cited by this paper
• Brain drug delivery of small molecules using immunoliposomes.

  1996cited by this paper
• Drug delivery through the blood-brain barrier

  1996cited by this paper
• Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles).

  1995cited by this paper
• Optimization of polyalkylcyanoacrylate nanoparticle preparation: Influence of sulfur dioxide and pH on nanoparticle characteristics

  1992cited by this paper
• A strategy for delivering peptides into the central nervous system by sequential metabolism.

  1992cited by this paper
• Studies on the transport pathway of PBCA nanoparticles in ocular tissues.

  1991cited by this paper
• Developments of a water-maze procedure for studying spatial learning in the rat.

  1984cited by this paper
• Pharmaceutical statistics: Practical and clinical applications

  1984cited by this paper

• Brain targeted drug delivery using liposomes and polymeric nanocarriers: Pharmaceutical and preclinical perspectives in Alzheimer's and Parkinson's disease

  2026cites this paper
• Nanomedicine for Treating Major Brain Diseases: Advances and Future Directions.

  2025cites this paper
• Development of Phytase Targeted PLGA Nanoparticles Loaded with Albendazole Sulfoxide and Praziquantel and Evaluation of Efficacy on the Hydatid Cysts

  2025cites this paper
• Optimized scleroglucan production by Athelia rolfsii and in vitro Sclg-5-fluorouracil release investigations.

  2024cites this paper
• Fabrication of carotenoid enriched Crocus sativus w/o nanoemulsion: Optimization and pharmaceutical characterization

  2024cites this paper
• Nanofiber Power: Reinforcing in-situ Hydrogel for Enhanced Rivastigmine Delivery

  2024cites this paper
• Formulation and characterization of polymeric nanoparticle of Rivastigmine for effective management of Alzheimer’s disease

  2024cites this paper
• Advancing anticorrosion and antibacterial performance of mg AZ31 implants using novel pH-responsive polymeric surfactant for preparing PLGA nanoparticles

  2024cites this paper
• Nanotechnology-empowered therapeutics targeting neurodegenerative diseases.

  2023cites this paper
• Nanomedicine-driven therapeutic interventions of autophagy and stem cells in the management of Alzheimer's disease.

  2023cites this paper
• Brain targeting based nanocarriers loaded with resveratrol in Alzheimer's disease: A review

  2023cites this paper
• Interaction of gentamicin and gentamicin-AOT with poly-(lactide-co-glycolate) in a drug delivery system - density functional theory calculations and molecular dynamics simulation.

  2023cites this paper
• Targeting the central nervous system: From synthetic nanoparticles to extracellular vesicles-Focus on Alzheimer's and Parkinson's disease.

  2023cites this paper
• Formulation and Optimization of Rivastigmine-Loaded PLGA and Chitosan Nanoparticles for Transdermal Delivery

  2023cites this paper
• Intramuscularly administered PLGA microparticles for sustained release of rivastigmine: in vitro, in vivo and histological evaluation.

  2023cites this paper
• An optimistic approach to nanotechnology in Alzheimer's disease management: An overview

  2023cites this paper
• Oral Dissolving Film of Rivastigmine: Optimization Using Factorial Design

  2023cites this paper
• Amyloid –β pathology in Alzheimer’s disease: A nano delivery approach

  2023cites this paper
• Polysorbate-coated mesoporous silica nanoparticles as an efficient carrier for improved rivastigmine brain delivery.

  2022cites this paper
• QbD-based rivastigmine tartrate-loaded solid lipid nanoparticles for enhanced intranasal delivery to the brain for Alzheimer's therapeutics

  2022influential citation
• An In Vivo Investigation of Ascorbic Acid Tethered Polymeric Nanoparticles for Effectual Brain Transport of Rivastigmine.

  2022cites this paper
• Benefits and limitations of nanomedicine treatment of brain cancers and age-dependent neurodegenerative disorders.

  2022cites this paper
• Extravaganza of Nanobiotechnology in the Diagnosis and Treatment of Dementia Patients.

  2022cites this paper
• Dual Vinorelbine bitartrate and Resveratrol loaded polymeric aqueous core nanocapsules for synergistic efficacy in breast cancer

  2022cites this paper
• Controlled release and targeted drug delivery with poly(lactic-co-glycolic acid) nanoparticles: reviewing two decades of research

  2022cites this paper
• Lung cancer targeting efficiency of Silibinin loaded Poly Caprolactone /Pluronic F68 Inhalable nanoparticles: In vitro and In vivo study

  2022cites this paper
• IN SITU ENCAPSULATION OF RIVASTIGMINE IN TAT-FUNCTIONALIZED P(MMA-co-AA) NANOPARTICLES THROUGH MINIEMULSION POLYMERIZATION

  2021cites this paper
• Organ-on-a-chip technology for nanoparticle research

  2021cites this paper
• Nanodelivery systems for Alzheimer’s disease: Prospects of natural therapeutic agents

  2021cites this paper
• DESIGN AND CHARACTERIZATION OF PRAMIPEXOLE

  2021cites this paper
• OPTIMIZATION AND CHARACTERIZATION OF RIVASTIGMINE-LOADED NANOSTRUCTURED LIPID CARRIERS

  2021cites this paper
• Fe3O4@SiO2@CeO2 as a potential nanomagnetic carrier for oral delivery system and release of Celecoxib.

  2021cites this paper
• Tumor-Targeted Delivery of Bufalin-Loaded Modified Albumin–Polymer Hybrid for Enhanced Antitumor Therapy and Attenuated Hemolysis Toxicity and Cardiotoxicity

  2021cites this paper
• Improved Controlled Release and Brain Penetration of the Small Molecule S14 Using PLGA Nanoparticles †

  2021cites this paper
• The application of multifunctional nanomaterials in Alzheimer's disease: A potential theranostics strategy.

  2021cites this paper
• Drug Delivery Systems and Strategies to Overcome the Barriers of Brain.

  2021cites this paper
• Optimized Rivastigmine Nanoparticles Coated with Eudragit for Intranasal Application to Brain Delivery: Evaluation and Nasal Ciliotoxicity Studies

  2021cites this paper
• Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases

  2021cites this paper
• Investigating the Internalization and COVID-19 Antiviral Computational Analysis of Optimized Nanoscale Zinc Oxide

  2021cites this paper
• Flavonoid-Based Nanomedicines in Alzheimer's Disease Therapeutics: Promises Made, a Long Way To Go.

  2021cites this paper
• Acetylcholinesterase inhibitors and nanoparticles on Alzheimer’s disease: a review

  2021cites this paper
• Nano Carrier Drug Delivery Systems for the Treatment of Neuropsychiatric Disorders: Advantages and Limitations

  2020cites this paper
• Fluorinated Molecules and Nanotechnology: Future ‘Avengers’ against the Alzheimer’s Disease?

  2020cites this paper
• Fabrication of chitosan/collagen/hydroxyapatite scaffolds with encapsulatedCissus quadrangularisextract

  2020cites this paper
• PLGA nanoparticle preparations by emulsification and nanoprecipitation techniques: effects of formulation parameters

  2020cites this paper
• Nanotechnology Based Delivery Systems of Drugs Currently Used to Treat Alzheimer’s Disease

  2020cites this paper
• Development of Alginate- Neusilin US2 (Magnesium alumino-metasilicate) micro-composite hydrogel beads for oral sustained release of cilnidipine: a statistical optimization

  2020cites this paper
• An integrated vitamin E-coated polymer hybrid nanoplatform: A lucrative option for an enhanced in vitro macrophage retention for an anti-hepatitis B therapeutic prospect

  2020cites this paper
• Multifunctional Polymeric Nanoplatforms for Brain Diseases Diagnosis, Therapy and Theranostics

  2020cites this paper
• In vitro anti-leukemic assessment and sustained release behaviour of cytarabine loaded biodegradable polymer based nanoparticles.

  2020cites this paper
• Riluzole-loaded nanoparticles to alleviate the symptoms of neurological disorders by attenuating oxidative stress

  2020cites this paper
• Brain Delivery of Nanomedicines: Trojan Horse Liposomes for Plasmid DNA Gene Therapy of the Brain

  2020cites this paper
• Nanotechnology-based approaches for tuberculosis treatment

  2020cites this paper
• Biomarker detection of Parkinson’s disease: therapy and treatment using nanomaterials

  2020cites this paper
• Nanomedicine against Alzheimer's and Parkinson's disease.

  2020cites this paper
• Lipid-core nanocapsules containing simvastatin improve the cognitive impairment induced by obesity and hypercholesterolemia in adult rats.

  2020cites this paper
• Eudragit®-S100 Coated PLGA Nanoparticles for Colon Targeting of Etoricoxib: Optimization and Pharmacokinetic Assessments in Healthy Human Volunteers

  2020cites this paper
• Double Optimization of Rivastigmine-Loaded Nanostructured Lipid Carriers (NLC) for Nose-to-Brain Delivery Using the Quality by Design (QbD) Approach: Formulation Variables and Instrumental Parameters

  2020cites this paper
• Biomaterials in Neurodegenerative Disorders: A Promising Therapeutic Approach

  2020cites this paper
• Therapeutic Nanoparticles and Their Targeted Delivery Applications

  2020cites this paper
• Bioinspired lipid-polysaccharide modified hybrid nanoparticles as a brain-targeted highly loaded carrier for a hydrophilic drug.

  2020cites this paper
• Neurotherapeutic applications of nanomedicine for treating Alzheimer's disease.

  2020cites this paper
• Poly(butyl cyanoacrylate) nanoparticle containing an organic photoCORM

  2019cites this paper
• Unraveling Binding Mechanism of Alzheimer’s Drug Rivastigmine Tartrate with Human Transferrin: Molecular Docking and Multi-Spectroscopic Approach towards Neurodegenerative Diseases

  2019cites this paper
• Formulation of acyclovir-loaded solid lipid nanoparticles: 2. Brain targeting and pharmacokinetic study

  2019cites this paper
• Optimization and characterization of sertaconazole nitrate flexisomes embedded in hydrogel for improved antifungal activity

  2019cites this paper
• Evaluation of Smart Polymers for Controlled Release Delivery Systems

  2019cites this paper
• Conclusion and Future Prospective of Polymeric Nanoparticles for Cancer Therapy

  2019cites this paper
• Nanobiotechnology in Neurodegenerative Diseases

  2019cites this paper
• SYNTHESIS, IN-SILICO PHYSICOCHEMICAL PROPERTIES AND ANTIMICROBIAL STUDIES OF PYRAZOLINE LOADED NANOPARTICLES

  2019cites this paper
• Gellan Gum-Based Hydrogel for the Transdermal Delivery of Nebivolol: Optimization and Evaluation

  2019cites this paper
• Scope of new formulation approaches in the repurposing of pioglitazone for the management of Alzheimer’s disease

  2019cites this paper
• Gastrointestinal Responsive Polymeric Nanoparticles for Oral Delivery of Insulin: Optimized Preparation, Characterization, and In Vivo Evaluation.

  2019cites this paper
• Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles

  2019cites this paper
• Drug targeting strategies into the brain for treating neurological diseases.

  2019cites this paper
• Formulation of polymeric nanoparticles of antidepressant drug for intranasal delivery.

  2019cites this paper
• DRUMSTICK MUCILAGE MICROSPHERES FOR CONTROLLED RELEASE OF LAMIVUDINE: DESIGN, OPTIMIZATION AND IN VITRO EVALUATION

  2019cites this paper
• Recent advances in the design and applications of amyloid-β peptide aggregation inhibitors for Alzheimer’s disease therapy

  2019cites this paper
• Overcoming the Blood–Brain Barrier. Challenges and Tricks for CNS Drug Delivery

  2019cites this paper
• In Vitro Release Test of Nano-drug Delivery Systems Based on Analytical and Technological Perspectives

  2019cites this paper
• Reactive oxygen species-responsive drug delivery systems for the treatment of neurodegenerative diseases.

  2019cites this paper
• Alzheimer's Disease Targeted Nano-Based Drug Delivery Systems.

  2019cites this paper
• Formulation and Evaluation of Eudragit RL-100 Nanoparticles Loaded In-Situ Forming Gel for Intranasal Delivery of Rivastigmine

  2019cites this paper
• Nanoparticulate Hydrogel Incorporated with Mimosa pudica Extract : Formulation and Characterization

  2018cites this paper
• An Alternative Approach for Improved Entrapment Efficiency of Hydrophilic Drug Substance in PLGA Nanoparticles by Interfacial Polymer Deposition Following Solvent Displacement

  2018cites this paper
• Permeability and in vivo distribution of poly(Ɛ-caprolactone) nanoparticles loaded with zidovudine

  2018cites this paper
• Optimizing the Delivery of 17β-estradiol: Maximizing Beneficial Cognitive Effects While Minimizing Undesired Peripheral Stimulation in a Rat Model of Surgical Menopause

  2018cites this paper
• Development of a nanoprecipitation method for the entrapment of a very water soluble drug into Eudragit RL nanoparticles

  2017cites this paper
• Mesoporous silica nanoparticles for efficient rivastigmine hydrogen tartrate delivery into SY5Y cells

  2017cites this paper
• Strategies of Engineering Nanoparticles for Treating Neurodegenerative Disorders.

  2017cites this paper
• Nanotechnology Based Theranostic Approaches in Alzheimer's Disease Management: Current Status and Future Perspective.

  2017cites this paper
• Formulation and statistical optimization of gastric floating alginate/oil/chitosan capsules loading procyanidins: in vitro and in vivo evaluations.

  2017cites this paper
• Nanobiomaterials’ applications in neurodegenerative diseases

  2017cites this paper
• Nanotechnology Based Approaches for Neurodegenerative Disorders: Diagnosis and Treatment

  2017cites this paper
• Scope of Lipid Nanoparticles in Neuroscience: Impact on the Treatment of Neurodegenerative Diseases.

  2017cites this paper
• Nanotechnology for Alzheimer Disease.

  2017cites this paper
• Development and Optimization of w/o/w Multiple Emulsion of LisinoprilDihydrate Using Plackett Burman and Box-Behnken Designs

  2017cites this paper
• Development and evaluation of bio-nanoparticles as novel drug carriers for the delivery of Donepezil

  2017cites this paper
• Nanocarriers for Effective Brain Drug Delivery.

  2017cites this paper
• 4.30 Nanomaterials for Drug Delivery to the Brain

  2017cites this paper